A purification method for deuterated benzoxazine
By using the reaction of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride and (2-acetyl-4-methylpentyl)trimethylammonium iodide under the action of an inorganic base, combined with purification with methanol and sodium carbonate aqueous solution, the problems of complex preparation process and low yield of deuterated butylbenazine in the prior art have been solved, and high-purity and high-yield deuterated butylbenazine has been prepared, which is suitable for industrial production.
Patent Information
- Application Number
- CN202611321586.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-08-28
- Publication Date
- 2026-11-17
AI Technical Summary
Existing methods for preparing deuterated butylbenazine are cumbersome, require large amounts of solvent, generate a lot of waste, have low yields, and suffer from side reactions and impurities that are difficult to remove.
6,7-Dimethoxy-3,4-dihydroisoquinoline hydrochloride and (2-acetyl-4-methylpentyl)trimethylammonium iodide were used as reactants and the reaction was carried out under the action of an inorganic base to reduce the occurrence of side reactions. The product was then purified with methanol and sodium carbonate aqueous solution. Finally, the product was purified twice by condensation reaction of deuterated methanol and sodium carbonate aqueous solution to improve the yield and purity of the product.
The preparation process is simplified, solvent use and waste emissions are reduced, and the yield and purity of deuterated butylbenazine are improved, making it suitable for large-scale industrial production.
Smart Images

Figure CN123106667A_ABST
Abstract
Description
[0001] This invention belongs to the field of pharmaceutical synthesis technology and relates to a simple and effective method for purifying deuterated benzoxazine. Background Technology
[0002] Huntington's disease (HD) is a rare and fatal neurodegenerative disorder, a dominant inherited neurodegenerative disease characterized by involuntary motor abnormalities and progressive dementia. It falls under the category of dynamic gene mutation diseases or polyglutamine repeat diseases. Tardive dyskinesia (TD) is a movement disorder that affects not only patient treatment adherence but also their quality of life and social functioning. Currently, there is no significantly effective treatment for TD in China. Bubenazine can significantly reduce abnormal involuntary movements in TD patients and is well-tolerated.
[0003] Deuterated bubenazine is a small-molecule oral inhibitor targeting vesicular monoamine transporter 2 (VMAT2). It is a deuterated form of bubenazine, a marketed drug for Huntington's disease. Higher deuterium mass results in stronger carbon binding, potentially altering drug pharmacokinetics, dosage, and tolerability. Through its breakthrough deuteration mechanism, the incorporation of deuterium into bubenazine effectively slows drug metabolism, doubles its half-life, and significantly improves pharmacokinetic characteristics, thereby reducing dosing frequency while enhancing efficacy, safety, and tolerability.
[0004] The chemical name of butylbenazine is: cis-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H-benzo[a]quinazine-2-one; the chemical name of the intermediate is: cis-9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinoline-2(11bH)-one; the chemical name of deuterated butylbenazine is: 6-deuterated-cis-9,10-dimethoxy-1,3,4,6,7-11b-hexahydro-3-isobutyl-2H-benzo[a]quinazine-2-one, and the specific structural formula is as follows.
[0005]
[0006] Patent WO080582612 reports a method for synthesizing bubenazine, but it contains many impurities, has a low yield, and requires column chromatography purification for each product, making it unsuitable for industrial production. The specific synthetic route is as follows:
[0007] Patent CN20121044289.9 reports a method for preparing butylbenazine, which uses a large amount of potassium hydroxide and acetyl chloride, increasing the difficulty and cost of the process. During the reaction, a large amount of diamine methyl substitution impurities are generated, affecting the purity of butylbenazine. The specific synthetic route is as follows:
[0008] Patent WO2019 / 150387A1 reports the synthesis of 6-deuterated-6,7-dimethoxy-3,4-dihydroisoquinoline, which reacts with 2-(acetyl-4-methylpentyl)trimethylammonium iodide to generate deuterated butylbenazine. The specific synthetic route is as follows:
[0009] Reducing the possibility of monosubstitution in the above reaction would require increasing the amount of deuterated reagent, increasing costs, complicating post-processing, and being environmentally unfriendly. Potential side reactions include:
[0010] Patent WO2017 / 182916A1 reports the preparation of butylbenazine and deuterated butylbenazine intermediates, as well as the synthesis of butylbenazine and deuterated butylbenazine. In the preparation of butylbenazine, the HPLC purity was 98.6%, and the molar yield was 68-70%. Example 6 describes the preparation of deuterated butylbenazine using 9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyridin[2,1-A]isoquinoline-2(11BH)-one:deuterated methanol at a molar ratio of 1:10. The deuterated methanol was added in large excess, which was detrimental to post-processing and caused significant pollution. With 3 kg of intermediate added, the scale-up yield was 1.75 kg, equivalent to a molar yield of approximately 50%, indicating a significant scale-up effect. Examples 7-8 all involve purification processes, which are cumbersome. Isopropanol was used as the purification solvent, and the molar yield after scale-up was only 52%, with a purity of 98.5%. After multiple purifications, the purity reached 99.7%. The specific synthetic route is as follows:
[0011] However, the content of byproducts is high, and the following side reactions exist:
[0012] Patent WO2019207517A1 reports a demethylation reaction using 10g of butylbenazine as a raw material, with a 33% acetic acid-hydrogen bromide solution and a 48% hydrogen bromide aqueous solution heated to 120°C for 8 hours. The reaction was then concentrated and the pH was adjusted to 7.0-7.5 with a 40% sodium carbonate solution. The mixture was then extracted and washed with ethyl acetate and sodium chloride aqueous solution. The organic phase was concentrated to obtain 6g of a mixture of deuterated butylbenazine intermediates (HPLC 96.5%, molar yield 66%). The reaction process generates significant acid fumes, and the sodium carbonate pH adjustment process releases a large amount of gas, posing a high risk of material spillage during scale-up production. The transportation and storage of the acetic acid-hydrogen bromide also present risks. Furthermore, the pH adjustment process generates acetate, which can easily form a buffer solution, leading to pH adjustment deviations. A low pH can result in unqualified isomers.
[0013] 80 g of deuterated butylbenazine intermediate was reacted with 45 ml of deuterated methanol at 60–90 °C for 1.5 h, then at 45–50 °C for 2 h. After cooling to room temperature, the mixture was filtered to obtain the filtrate. Sodium sulfate and water were added, and the mixture was stirred to separate the phases. The pH of the aqueous phase was adjusted to 9–10 with ammonia and stirred for 30 min. After cooling to 0–5 °C, the mixture was stirred for 1–1.5 h and filtered. The solid was dissolved in isopropanol and recrystallized to obtain 65 g of deuterated butylbenazine. The HPLC yield was 99.48%, and the molar yield was 72%. The entire post-processing was complex, the yield was low, and there were problems with single-substitution side reactions and high levels of single-substitution impurities. The specific synthetic route is as follows:
[0014] In Example 1 of patent US10479787B2, the reaction temperature was 45-50℃, and after the reaction, only filtration and washing with water were performed, yielding only 138g, with a molar yield of 66%. In Example 4, 10g of butylbenazine was passed through a micron filter, and the filtrate was crystallized with n-heptane and dried to obtain 9.6g of butylbenazine. In Example 8, 1.7kg of deuterated butylbenazine was filtered through a micron filter, concentrated, and then dissolved and crystallized in isopropanol to obtain 1.53kg, with a yield of 90% and an HPLC accuracy of 99.7%. Compared with the two examples, the purification process of deuterated butylbenazine was not as effective as that of butylbenazine, requiring further purification after micron filtration. This indicates that only the specified impurities in deuterated butylbenazine can be filtered out, and other impurities need to be treated by crystallization and other methods. Summary of the Invention
[0015] The purpose of this invention is to address the problems of existing preparation methods, such as cumbersome operation, high solvent requirements, large waste emissions, and low yield, by providing a purification method for deuterated butylbenazine. First, 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride and (2-acetyl-4-methylpentyl)trimethylammonium iodide are used as reactants. No phase transfer catalyst is needed; the reaction proceeds forward under the action of an inorganic base alone, reducing side reactions and improving the yield and purity of the crude butylbenazine product. Then, methanol and sodium carbonate aqueous solution are used as solvents to purify the crude butylbenazine, making... Impurities are easier to remove, resulting in significantly improved yield and purity. Then, butylbenazine is chemically reacted with acetic acid and acetyl bromide to prepare an intermediate with high yield and purity. Finally, the obtained intermediate is condensed with deuterated methanol to prepare the target product, deuterated butylbenazine. The crude product is purified twice, sequentially in methanol and sodium carbonate aqueous solution and acetone and sodium carbonate aqueous solution, which can significantly remove individual deuterated products, greatly increasing the deuteration rate of the product and further improving the yield and purity of the target product. The entire preparation method is simple and convenient, with a simple post-processing procedure, requiring no column chromatography purification, and exhibiting high yield and purity, making it suitable for large-scale industrial production.
[0016] The technical solution of the present invention is as follows: A method for purifying deuterated butylbenazine includes the following steps: (1) Preparation of butylbenazine: 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride, (2-acetyl-4-methylpentyl)trimethylammonium iodide, inorganic base, water and solvent I are mixed evenly and chemically reacted at 30-50℃ to prepare crude butylbenazine; the crude product is then added to methanol and potassium carbonate aqueous solution and stirred to dissolve at 50-80℃, cooled to 20-30℃, filtered and dried to obtain purified butylbenazine; (2) Preparation of intermediate: The butylbenazine obtained in step (1), acetic acid, water and acetyl bromide are mixed evenly and chemically reacted at 80-120℃ to prepare the intermediate; (3) Preparation of deuterated butylbenazine: The intermediate obtained in step (2), triphenylphosphine, solvent II, deuterated methanol and DIAD are mixed evenly and chemically reacted at 30-50℃ to prepare crude deuterated butylbenazine; the crude product is then added to methanol and potassium carbonate aqueous solution and stirred and dissolved for the first time at 50-80℃, cooled to 20-30℃, filtered, and the resulting filter cake is added to acetone and potassium carbonate aqueous solution and stirred and dissolved for the second time at 50-80℃, cooled to 20-30℃, filtered, and dried to obtain purified deuterated butylbenazine; the specific synthetic route is as follows:
[0017] For the purposes of this invention, in step (1), the reaction temperature is 30-50°C; preferably, the reaction temperature is 35-40°C; more preferably, the reaction temperature is 35°C.
[0018] In step (1), the inorganic base is sodium carbonate or potassium carbonate, preferably potassium carbonate.
[0019] In step (1), solvent I is methanol or ethanol, preferably methanol.
[0020] For the purposes of this invention, in step (1), the mass ratio of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride to (2-acetyl-4-methylpentyl)trimethylammonium iodide is 1:1.0-2.0, preferably, the mass ratio of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride to (2-acetyl-4-methylpentyl)trimethylammonium iodide is 1:1.3-1.5.
[0021] In step (1), the mass ratio of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride to potassium carbonate is 1:0.2-1.0; preferably, the mass ratio of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride to potassium carbonate is 1:0.5-0.7; more preferably, the mass ratio of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride to potassium carbonate is 1:0.6.
[0022] In step (1), the obtained crude product is added to methanol and potassium carbonate aqueous solution. The mass percentage of potassium carbonate aqueous solution is 0.1%-5%, which can be, but is not limited to, 0.1%, 0.3%, 0.5%, 0.6%, 0.8%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5% or 5%. Preferably, the mass percentage of potassium carbonate aqueous solution is 0.5%-1%.
[0023] In step (1), the obtained crude product is added to an aqueous solution of methanol and potassium carbonate and stirred and dissolved at 50-80°C. Preferably, the stirring and dissolving temperature is 55-75°C; more preferably, the stirring and dissolving temperature is 60-70°C.
[0024] In this invention, in step (2), the butylbenazine obtained in step (1), acetic acid, water and acetyl bromide are mixed evenly and chemically reacted at 80-120°C. Preferably, the reaction temperature is 85-115°C; more preferably, the reaction temperature is 90-110°C.
[0025] In step (2), the mass ratio of butylbenazine to acetyl bromide is 1:7-10, preferably 1:8.5-9.5, and more preferably 1:9.
[0026] In this invention, in step (3), the reaction temperature is 30-50°C, preferably 35-40°C.
[0027] In step (3), the mass ratio of the intermediate to triphenylphosphine is 1:2.0-3.5, preferably 1:2.5-3.0, and more preferably 1:2.6-2.8.
[0028] In step (3), the mass ratio of the intermediate to deuterated methanol is 1:0.2-1.0, preferably 1:0.4-0.6, and more preferably 1:0.5.
[0029] In step (3), the mass ratio of the intermediate to DIAD is 1:1.5-3.5, preferably 1:1.8-2.2, and more preferably 1:2.1.
[0030] In step (3), solvent II is toluene, dichloromethane or xylene, preferably toluene.
[0031] In this invention, in step (3), the obtained crude product is first added to methanol and potassium carbonate aqueous solution. The mass percentage of potassium carbonate aqueous solution is 0.1%-5%, which can be, but is not limited to, 0.1%, 0.3%, 0.5%, 0.6%, 0.8%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5% or 5%. Preferably, the mass percentage of potassium carbonate aqueous solution is 0.5%-1%.
[0032] In step (3), the crude product is first added to an aqueous solution of methanol and potassium carbonate, and stirred and dissolved for the first time at 50-80°C. Preferably, the temperature of the first stirring and dissolution is 55-75°C; more preferably, the temperature of the first stirring and dissolution is 60-70°C.
[0033] In this invention, in step (3), the obtained filter cake is added to an aqueous solution of acetone and potassium carbonate. The mass percentage of the aqueous solution of potassium carbonate is 0.1%-5%, which may be, but is not limited to, 0.1%, 0.3%, 0.5%, 0.6%, 0.8%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5% or 5%. Preferably, the mass percentage of the aqueous solution of potassium carbonate is 0.5%-1%.
[0034] In step (3), the obtained filter cake is added to an aqueous solution of acetone and potassium carbonate and stirred and dissolved for the second time at 50-80°C. Preferably, the temperature of the second stirring and dissolution is 55-75°C; more preferably, the temperature of the second stirring and dissolution is 60-70°C.
[0035] The advantages of using the technical solution of this invention are as follows: The purification method for deuterated butylphenazine provided by this invention first uses 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride and (2-acetyl-4-methylpentyl)trimethylammonium iodide as reaction raw materials. No phase transfer catalyst is needed; the reaction proceeds forward under the action of an inorganic base alone, reducing side reactions and improving the yield and purity of the crude butylphenazine product. Then, methanol and sodium carbonate aqueous solution are used as solvents to purify the crude butylphenazine, making impurities easier to remove and significantly improving the yield and purity. Finally, butylphenazine is reacted with acetic acid... The intermediate is prepared by chemical reaction with acetyl bromide, achieving high yield and purity. The obtained intermediate is then condensed with deuterated methanol to prepare the target product, deuterated butylbenazine. The crude product is purified twice, sequentially in methanol and sodium carbonate aqueous solution, and then in acetone and sodium carbonate aqueous solution. This significantly removes individual deuterated products, greatly increasing the deuteration rate and further improving the yield and purity of the target product. The entire preparation method is simple and convenient, with minimal post-processing, eliminating the need for column chromatography purification. Furthermore, it boasts high yield and purity, making it suitable for large-scale industrial production. The alkaline mother liquor remaining during the butylbenazine reaction can be used as a tail gas absorbent for the intermediate, greatly reducing tail gas emissions and waste discharge, thus being environmentally friendly and meeting the requirements of green chemistry production. Attached Figure Description
[0036] Figure 1 It is the deuterated butylbenazine in Example 1. 1 H NMR spectrum; Figure 2 This is the IR spectrum of deuterated butylbenazine in Example 1. Detailed Implementation
[0037] The present invention can be better understood from the following embodiments. However, those skilled in the art will readily understand that the descriptions in the embodiments are for illustrative purposes only and should not, and will not, limit the invention as detailed in the claims.
[0038] Example 1 A method for purifying deuterated butylbenazine, comprising the following steps: (1) Preparation of butylbenazine: 900g of water, 300g of methanol, 180g of potassium carbonate, 300g of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride and 450g of (2-acetyl-4-methylpentyl)trimethylammonium iodide were stirred and mixed evenly. The mixture was stirred and reacted at 35-40℃ for 30 hours. The resulting reaction solution was cooled to 35℃, filtered, the filter cake was washed with water and dried to obtain 395.5g of crude butylbenazine. The HPLC normalization was 99.38% and the molar yield was 94.5%.
[0039] The obtained 395.5g crude product was added to 480g methanol and 1200g 0.5% potassium carbonate aqueous solution. The resulting mixed solution was stirred and dissolved at 60-70℃ for 3 hours, then cooled to 20-30℃, filtered, and the filter cake was dried to obtain 386.4g of purified butylbenazine. The purified molar yield was 97.68%, and the HPLC normalization was 99.89%.
[0040] (2) Preparation of intermediate: 840g of acetic acid and 1000g of water were mixed evenly, and 252g of the purified butylbenazine obtained in step (1) was added. Then, 2268g of acetyl bromide was added dropwise. After the addition was completed, the resulting mixed solution was heated to 90-110℃ and stirred for 24 hours. After the reaction was completed, the resulting reaction solution was cooled to 20-30℃, and the pH was adjusted to 9-10 with concentrated ammonia. The solution was filtered, and the filter cake was dissolved in 500g of methanol and 5g of acetic acid by stirring. The solution was then cooled to 20-30℃, filtered, and dried to obtain 191.1g of intermediate (9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyridine[2,1-A]isoquinoline-2(11BH)-one), with a molar yield of 83% and HPLC normalization ≥99.8%.
[0041] (3) Preparation of deuterated butylbenazine: Add 100g of the intermediate obtained in step (2), 273g of triphenylphosphine and 50g of deuterated methanol to 1000g of toluene. After stirring and mixing evenly, add 210g of DIAD dropwise to the resulting mixed solution at 35-40℃. After the addition is complete, stir and react for 3 hours at 35-40℃. Cool the resulting reaction solution to 20-30℃, filter, add 500g of water to the filtrate, adjust the pH to 1-2 with 20% sulfuric acid solution and separate the phases. Add 800g of ethyl acetate to the resulting aqueous phase, adjust the pH to 8-9 with concentrated ammonia, concentrate and dry to obtain 97g of the mixture.
[0042] Add 250g methanol and 500g 0.5% potassium carbonate solution to the mixture. The resulting solution is stirred and dissolved for 1-2 hours at 60-70℃. After cooling to 20-30℃, filter. Add 250g acetone and 500g 0.5% potassium carbonate solution to the filter cake. Stir and dissolve the resulting solution for 1-2 hours at 60-70℃. Then cool to 20-30℃. Dry the filter cake under reduced pressure to obtain 93.6g deuterated butylbenazine, with a molar yield of 83.7% and an HPLC purity of 99.74%. The monohydroxy purity is 0.014%, the diastereomer is 0.1%, the total impurities are 0.155%, and the deuterated content is 100%.
[0043] The specific synthesis route is as follows:
[0044] Among them, the deuterated content is determined by...1 The H NMR calculations are performed as follows:
[0045] Example 2 Preparation of Butenaazine The difference from step (1) in Example 1 is that the solvent methanol was replaced with ethanol, and after the same operation, 364.2g of crude butylbenazine was obtained by drying, with a molar yield of 87.0% and an HPLC normalization of 98.32%; the crystallization solvent methanol was replaced with ethanol, and after the same operation, 364.2g of crude butylbenazine was dried by filter cake to obtain 347.1g of refined butylbenazine, with a purification molar yield of 95.3% and an HPLC normalization of 99.63%.
[0046] Example 3 Preparation of Butenazine The difference from step (1) in Example 1 is that the amount of (2-acetyl-4-methylpentyl)trimethylammonium iodide added was reduced from 450g to 414g (mass ratio of 1:1.38). After the same operation, 378g of crude butylbenazine was obtained by drying, with a molar yield of 90.3%. After the same crystallization operation, 367.2g of refined butylbenazine was obtained by drying the filter cake, with a refined molar yield of 97.1% and HPLC normalization of 99.27%.
[0047] Example 4 Preparation of Butenazine Following the steps in Example 1, 100g of crude butylbenazine was obtained and added to 320g of methanol and 800g of 5% potassium carbonate aqueous solution. After the same operation, the product was dried to obtain 92.7g of purified butylbenazine, with a purification molar yield of 92.7% and HPLC normalization of 99.89%. The difference from Example 1 is that the concentration of potassium carbonate aqueous solution was increased from 0.5% to 5% during purification.
[0048] Example 5 Preparation of intermediates The 252g of butylbenazine obtained in Example 2 was used to prepare an intermediate according to step (2) in Example 1, except that the amount of acetyl bromide was reduced from 2268g to 1764g (the mass ratio was reduced from 9:1 to 7:1). After the same operation, 172g of intermediate was obtained, with a molar yield of 74.7% and HPLC normalization ≥99.8%.
[0049] Example 6 Preparation of deuterated butylbenazine Take 100g of the intermediate obtained in Example 5 and operate according to step (3) in Example 1. Dry the mixture to obtain 96g. Add 250g of methanol and 0.1% potassium carbonate solution to the mixture. Stir and dissolve the resulting mixture at 60-70℃ for 1-2 hours. Cool to 20-30℃ and filter. Add 250g of acetone and 500g of 0.1% potassium carbonate solution to the filter cake. After the same operation, dry to obtain 92g of deuterated butylbenazine. The molar yield is 82.3% and the HPLC purity is 99.11%. The difference from Example 1 is that the concentration of potassium carbonate aqueous solution is reduced from 0.5% to 0.1% during the two purification processes.
[0050] Comparative Example 1 10g of the purified butylbenazine obtained in Example 1 was dissolved in 20ml of acetic acid at 25-30℃, followed by the addition of 60ml of 33% acetic acid-hydrobromic acid solution and 30ml of 48% hydrobromic acid solution. The resulting mixture was reacted at 120℃ for 8 hours. The resulting reaction solution was cooled to 50℃, and the solvent was distilled under reduced pressure to obtain the residue. The residue was dissolved in water, and the resulting mixture was cooled to 10-15℃. The pH was adjusted to 7.0-7.5 with 100ml of 40% sodium carbonate solution, extracted with ethyl acetate (3 x 100ml), washed with sodium chloride solution (100ml), and concentrated to obtain 6g of intermediate (9,10-dihydroxy-3-isobutyl-3,4,6,7-tetrahydro-1H-pyridine[2,1-A]isoquinoline-2(11BH)-one). The purity was determined by HPLC to be 96.5%, and the molar yield was 65.7%.
[0051] Comparative Example 2 675 ml of methanol, 150 g of 3,4-dihydro-6,7-dihydroxyisoquinoline hydrochloride, 225 ml of water, 285 g of (2-acetyl-4-methylpentyl)trimethylammonium iodide, and 34.5 g of potassium carbonate were mixed thoroughly and reacted at 45-50 °C for 30 hours. The resulting reaction solution was cooled to 25-30 °C, and 450 ml of water was added. The mixture was stirred for 4 hours. The solid was filtered, washed with water, and dried under vacuum. The intermediate yield was 138 g, with a molar yield of 63.6% and a purity of 98.6%.
[0052] Comparative Example 3 Dissolve 80g of the intermediate obtained in Example 1 in 320ml of toluene. Add 45ml of deuterated methanol, 218g of triphenylphosphine, and 165mL of diisopropyl dicarboxylate at 30-35℃. After stirring thoroughly, react at 60-90℃ for 1.5 hours, then at 45-50℃ for 2 hours. Cool the resulting reaction solution to 30±5℃, filter, wash the filtrate with 80ml of toluene, add 30g of sodium sulfate and 300ml of water, and stir at 30-35℃ for 30-45 minutes. Collect the aqueous phase, adjust the pH to 9-10 with ammonia, and stir for 30-40 minutes. Cool again to 0-5℃ and stir for 1-1.5 hours. Filter the solid, wash with 240ml of water, add 160ml of isopropanol, and stir at 80-85℃ for 30-40 minutes. Cool to 0-5℃ and stir for 1-1.5 hours. The solid was filtered, the filter cake was washed with 40 ml of isopropanol, and dried in a vacuum drying oven at 50-55℃ for 3-4 hours to obtain 65 g of the product deuterated butylbenazine. HPLC: 99.48%, molar yield 72.6%.
[0053] Comparative Example 4 10g of the intermediate obtained in Example 1, 12.5g of deuterated methanol, and 27.2g of triphenylphosphine were added to 80ml of dichloromethane and stirred until homogeneous to obtain a mixed solution. 21g of azobisisopropyl dicarboxylate was added to 20ml of dichloromethane and stirred until homogeneous. The mixture was then added dropwise to the above mixed solution under controlled temperature of 25-30℃ and stirred for 2 hours. After the reaction was complete, the phases were washed with water and separated. The organic phase was concentrated under reduced pressure. After concentration, toluene was added, and the mixture was stirred and filtered. The filtrate was washed three times with 50ml of 5% sodium bisulfate aqueous solution. The aqueous layers were collected and the pH was adjusted to 9-11 with ammonia solution. 100ml of dichloromethane was added for washing and separation. The organic layer was concentrated under reduced pressure. After concentration, 100ml of ethyl acetate was added, and the mixture was concentrated again under reduced pressure. After concentration, 20ml of isopropanol was added and stirred until homogeneous. The mixture was heated to 75-80℃ and stirred for 15-30 minutes. The solid was cooled and filtered, washed with isopropanol, and dried under vacuum to obtain 5.83 g of deuterated butylbenazine with an HPLC purity of 98.5% and a molar yield of 52%.
[0054] The above embodiments are only used to illustrate the technical solutions of the present invention, and are not intended to limit it. Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art should understand that modifications may still be made to the technical solutions described in the foregoing embodiments, or equivalent substitutions may be made to some of the technical features. Such modifications or substitutions do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. A method for purifying deuterated butylbenazine, characterized in that, Includes the following steps: (1) Preparation of butylbenazine: 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride, (2-acetyl-4-methylpentyl)trimethylammonium iodide, inorganic base, water and solvent I are mixed evenly and chemically reacted at 30-50℃ to prepare crude butylbenazine; the crude product is then added to methanol and potassium carbonate aqueous solution and stirred to dissolve at 50-80℃, cooled to 20-30℃, filtered and dried to obtain purified butylbenazine; (2) Preparation of intermediate: The butylbenazine obtained in step (1), acetic acid, water and acetyl bromide are mixed evenly and chemically reacted at 80-120℃ to prepare the intermediate; (3) Preparation of deuterated butylbenazine: The intermediate obtained in step (2), triphenylphosphine, solvent II, deuterated methanol and DIAD are mixed evenly and chemically reacted at 30-50℃ to prepare crude deuterated butylbenazine; the crude product is then added to methanol and potassium carbonate aqueous solution and stirred and dissolved for the first time at 50-80℃, cooled to 20-30℃, filtered, and the resulting filter cake is added to acetone and potassium carbonate aqueous solution and stirred and dissolved for the second time at 50-80℃, cooled to 20-30℃, filtered, and dried to obtain purified deuterated butylbenazine; the specific synthetic route is as follows:
2. The purification method of deuterated butylbenazine according to claim 1, characterized in that, In step (1), the reaction temperature is 35-40℃, preferably 35℃; the inorganic base is sodium carbonate or potassium carbonate, preferably potassium carbonate; and solvent I is methanol or ethanol, preferably methanol.
3. The purification method for deuterated butylbenazine according to claim 2, characterized in that, In step (1), the mass ratio of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride to (2-acetyl-4-methylpentyl)trimethylammonium iodide is 1:1.0-2.0, preferably 1:1.3-1.5; the mass ratio of 6,7-dimethoxy-3,4-dihydroisoquinoline hydrochloride to potassium carbonate is 1:0.2-1.0, preferably 1:0.5-0.7, and more preferably 1:0.
6.
4. The purification method of deuterated butylbenazine according to claim 1, characterized in that, In step (1), the mass percentage of the potassium carbonate aqueous solution is 0.1%-5%, preferably 0.5%-1%; the stirring and dissolving temperature is 55-75℃, preferably 60-70℃.
5. The purification method of deuterated butylbenazine according to claim 1, characterized in that, In step (2), the reaction temperature is 85-115℃, preferably 90-110℃; the mass ratio of butylbenazine to acetyl bromide is 1:7-10, preferably 1:8.5-9.5, and more preferably 1:
9.
6. The purification method of deuterated butylbenazine according to claim 1, characterized in that, In step (3), the reaction temperature is 35-40℃; the mass ratio of the intermediate to triphenylphosphine is 1:2.0-3.5, preferably 1:2.5-3.0, and more preferably 1:2.6-2.
8.
7. The purification method of deuterated butylbenazine according to claim 1, characterized in that, In step (3), the mass ratio of the intermediate to deuterated methanol is 1:0.2-1.0, preferably 1:0.4-0.6, more preferably 1:0.5; the mass ratio of the intermediate to DIAD is 1:1.5-3.5, preferably 1:1.8-2.2, more preferably 1:2.
1.
8. The purification method of deuterated butylbenazine according to claim 1, characterized in that, In step (3), solvent II is toluene, dichloromethane or xylene, preferably toluene.
9. The purification method of deuterated butylbenazine according to claim 1, characterized in that, In step (3), the mass percentage of the potassium carbonate aqueous solution is 0.1%-5%, preferably 0.5%-1%.
10. The method for purifying deuterated butylbenazine according to claim 1, characterized in that, In step (3), the first stirring and dissolving temperature is 55-75℃, preferably 60-70℃; the second stirring and dissolving temperature is 55-75℃, preferably 60-70℃.
Citation Information
Patent Citations
Process for preparation of tetrabenazine and deutetrabenazine
US10479787B2
Microemulsions with adsorbed macromoelecules and microparticles
WO2000050006A2
Novel process for preparation of tetrabenazine and deutetrabenazine
WO2017182916A1
A novel process for preparation of deutetrabenazine
WO2019150387A1
Process for preparation of ((3r,11br)-1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d 3)-3-(2-methylpropyl)-2h-benzo[a]quinolizin-2-one
WO2019207517A1
